{"filings":[{"id":945437,"accession_number":"0001628280-26-041886","cik":1673743,"company_name":"Hinge Health, Inc.","ticker":"HNGE","form_type":"8-K","filed_at":"2026-06-09T20:06:49+00:00","items":["7.01","9.01"],"status":"ready","headline":"Hinge Health raises FY 2026 revenue guidance to $818-824M, up $20M at midpoint","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY 2026 revenue guided $818-824M, up from prior range; represents 40% YoY growth at midpoint.","FY 2026 non-GAAP operating margin expected ~27% midpoint; operating income $217-227M.","Q2 2026 revenue guided $200-202M (45% YoY growth); non-GAAP op income $50-52M (25% margin).","Company cites momentum, higher member conversion, and client performance; inaugural Investor Day June 10."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4185878207.6670394,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":861476,"accession_number":"0001628280-26-040802","cik":1673743,"company_name":"Hinge Health, Inc.","ticker":"HNGE","form_type":"8-K","filed_at":"2026-06-04T20:19:58+00:00","items":["5.07"],"status":"ready","headline":"Hinge Health stockholders elect Teddie Wardi and Tyler Sloat as Class I directors, ratify Deloitte as auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Teddie Wardi received ~276.9M votes for, ~14.9M withheld; Tyler Sloat received ~291.3M for, ~0.5M withheld.","Appointment of Deloitte & Touche LLP as independent auditor for FY 2026 ratified with ~305.8M for, ~0.1M against, ~0.1M abstain.","No broker non-votes on auditor ratification; meeting held June 3, 2026.","All proposals passed with substantial support."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":4185878207.6670394,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94580,"accession_number":"0001628280-26-030499","cik":1673743,"company_name":"Hinge Health, Inc.","ticker":"HNGE","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Hinge Health Q1 revenue $182M (+47% YoY), EPS $0.41; raises FY guidance to $801M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $182.3M, +47% YoY; GAAP diluted EPS $0.41, non-GAAP $0.45.","GAAP operating income $32.1M (+144% YoY); non-GAAP operating income $46.2M (+208% YoY).","Full year 2026 revenue guidance raised to $798M-$804M (midpoint $801M, +36% YoY).","Q2 2026 revenue guidance $194M-$196M, non-GAAP operating margin ~25%.","LTM calculated billings $769.9M (+52% YoY); clients up 23% to 2,849."],"consensus_eps_estimate":null,"consensus_eps_actual":0.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":182307000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":4185878207.6670394,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107074,"accession_number":"0001628280-26-018710","cik":1673743,"company_name":"Hinge Health, Inc.","ticker":"HNGE","form_type":"8-K","filed_at":"2026-03-17T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Hinge Health appoints Tyler Sloat to Board of Directors, effective March 16, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Tyler Sloat appointed as Class I director; term expires at 2026 annual meeting.","Sloat serves as COO of Freshworks (since Aug 2024) and former CFO of Zuora (2010-2020).","Initial RSU grant of $400k vesting over three years; annual cash fees of $65k (Board $40k, Comp Chair $15k, Audit $10k) elected as RSUs.","There are no arrangements or family relationships requiring disclosure under Item 404(a)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":4185878207.6670394,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107073,"accession_number":"0001628280-26-006826","cik":1673743,"company_name":"Hinge Health, Inc.","ticker":"HNGE","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Hinge Health Q4 revenue $170.7M (+46% YoY); guides FY26 rev $732-742M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $170.7M (+46% YoY); GAAP diluted EPS $0.37, non-GAAP $0.49.","Full-year revenue $587.9M (+51% YoY); GAAP op loss $546.4M, non-GAAP op income $119.5M.","Free cash flow $179.6M in 2025 (+297% YoY); Rule of 40 improved to 81 from 45.","FY 2026 revenue guidance $732-742M (+25% midpoint); non-GAAP op margin 21%.","Clients up 25% to 2,830; members up 47% to 782,890; contracted lives 25M."],"consensus_eps_estimate":null,"consensus_eps_actual":-7.77,"consensus_revenue_estimate":null,"consensus_revenue_actual":587860000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4185878207.6670394,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123411,"accession_number":"0001193125-25-276208","cik":1673743,"company_name":"Hinge Health, Inc.","ticker":"HNGE","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Hinge Health authorizes $250M share repurchase; Q3 free cash flow $118M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved up to $250M repurchase of Class A common stock on Nov 10, 2025.","Q3 2025 cash from operations $108M, free cash flow $118M; cash and investments ~$500M.","Repurchases may be made in open market or private transactions; no minimum obligation.","Company expects to fund repurchases with existing cash and cash from operations.","Buyback may be modified, suspended, or terminated at any time at board's discretion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4185878207.6670394,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123410,"accession_number":"0001193125-25-264667","cik":1673743,"company_name":"Hinge Health, Inc.","ticker":"HNGE","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Hinge Health Q3 revenue $154.2M (+53% YoY); raises FY 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $154.2M vs $100.6M in Q3 2024, +53% YoY; GAAP gross margin 82% vs 79%.","Non-GAAP income from operations $30.4M vs loss of $3.7M a year ago; free cash flow $81.3M.","Lifetime members surpassed 1.5M; client count up 25% to 2,560; LTM billings $624.2M (+50%).","FY 2025 revenue guidance raised to $572M-$574M (47% YoY growth at midpoint); non-GAAP op income $106M-$108M.","Q4 2025 revenue guided $155M-$157M (+33% YoY at midpoint); non-GAAP op income $34M-$36M."],"consensus_eps_estimate":null,"consensus_eps_actual":-9.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":417134000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":4185878207.6670394,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140077,"accession_number":"0000950170-25-108048","cik":1673743,"company_name":"Hinge Health, Inc.","ticker":"HNGE","form_type":"8-K","filed_at":"2025-08-13T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Hinge Health lock-up early release triggered; ~1.66M shares unlocked Aug 19","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Early release condition satisfied on Aug 6: stock price >120% of IPO price for 5+ days in 10-day window after Q1 earnings (Aug 5).","Approximately 1.66 million shares held by eligible employees/service providers become eligible for sale on Aug 19, 2025.","The early release applies to 25% of eligible shares; remaining shares stay locked up for full 180-day period from May 21, 2025.","Sales remain subject to Rule 144, Rule 701, and the company’s insider trading policy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4185878207.6670394,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140076,"accession_number":"0000950170-25-103024","cik":1673743,"company_name":"Hinge Health, Inc.","ticker":"HNGE","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Hinge Health Q2 revenue $139.1M (+55% YoY); non-GAAP operating income $26.1M; guides FY revenue $548-552M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue grew 55% YoY to $139.1M; GAAP gross margin 70%, non-GAAP gross margin 83%.","GAAP loss from ops $580.7M (incl $591M stock-based comp); non-GAAP income from ops $26.1M vs loss $14.4M.","Free cash flow $32.6M (incl $14.2M IPO tax adjustment) vs $14.0M; cash $415.1M.","Clients up 32% to 2,359; LTM calculated billings $568.4M, +55% YoY.","Q3 rev guidance $141-143M (41% YoY growth); FY rev guidance $548-552M (41% YoY growth)."],"consensus_eps_estimate":null,"consensus_eps_actual":-15.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":262923000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4185878207.6670394,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157724,"accession_number":"0001193125-25-125916","cik":1673743,"company_name":"Hinge Health, Inc.","ticker":"HNGE","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Hinge Health completes IPO of 15.7M shares at $32.00, raising $272.7M in gross proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO closed May 23, 2025; 15,715,900 shares of Class A common stock sold at $32.00 per share.","Company sold 8,522,528 shares for gross proceeds of $272.7M; selling stockholders sold 7,193,372 shares.","Underwriters exercised option to purchase an additional 2,049,900 shares from selling stockholders.","Amended certificate of incorporation and bylaws became effective in connection with the IPO closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":4185878207.6670394,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}